The MDSCs, in synergism with T-regs and B-regs, produce molecules that effectively suppress CD4+ T cells, CD8+ T cells, NK cells, NKT cells, and APCs, as well as supporting BC TME development [220]. The gene discussed is CD8A; the disease is breast cancer.